ACADIA Pharmaceuticals Inc. (ACAD)

Last Closing Price: 17.59 (2026-11-19)

Income after Taxes (Quarterly)

Income after Taxes: Earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.

ACADIA Pharmaceuticals Inc. (ACAD) had Income after Taxes of $53.52M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$342.29M
$53.52M
$35.09M
$307.20M
$270.57M
$71.72M
$8.72M
$80.44M
$80.44M
Income after Taxes
$53.52M
$53.52M
$53.52M
$53.52M
$71.72M
$75.23M
172.54M
175.47M
$0.31
$0.31
Balance Sheet Financials
$1.27B
$18.40M
$525.73M
$1.79B
$332.22M
--
$74.44M
$406.66M
$1.39B
$1.25B
$1.39B
172.79M
Cash Flow Statement Financials
$146.26M
$-28.40M
$26.60M
$185.54M
$330.21M
$144.67M
$49.09M
--
--
Fundamental Metrics & Ratios
3.82
--
--
--
--
89.75%
20.95%
20.95%
--
23.50%
15.64%
$134.72M
--
--
--
0.19
0.87
1.92
46.89
3.86%
4.28%
2.98%
3.86%
$8.03
$0.77
$0.83